Timing note: The supplied event date—August 6, 2026—is today, not tomorrow. This preview treats the report as still upcoming on August 6.
Expect a weak-looking quarter; the real debate is whether Q2 represents the earnings trough.
Molson Coors already warned that Q2 would combine:
Accordingly, the stock’s reaction should depend less on whether Q2 earnings decline and more on three questions:
A clean guidance reaffirmation accompanied by improving U.S. consumption trends would support the argument that most of the bad news is already reflected in TAP’s valuation. A guidance reduction—particularly one caused by deteriorating brand volumes rather than cost timing—would undermine that thesis.
| Metric | 2026 Q1 result |
|---|---|
| Net sales | $2.35 billion, +0.1% constant currency |
| Worldwide brand volume | -3.1% |
| U.S. brand volume | -3.5% |
| Underlying pretax income | $147.9 million, +16.2% constant currency |
| Underlying EPS | $0.62, +24.0% |
| Net debt / underlying EBITDA | 2.51x |
Q1 earnings were helped by expense timing, lower employee costs, the absence of approximately $30 million of prior-year Fever-Tree transition costs and continued share repurchases. Those benefits make Q1 a poor run-rate quarter: management explicitly said MG&A and commodity pressure would intensify in Q2.
| Metric | 2025 Q2 |
|---|---|
| Net sales | $3.20 billion |
| Financial volume | 20.87 million hectoliters |
| Worldwide brand volume | 20.61 million hectoliters |
| Underlying pretax income | $531.5 million |
| Underlying EPS | $2.05 |
Last year’s quarter benefited from shipment timing and lower incentive compensation. That creates a difficult earnings comparison even before this year’s commodity inflation and elevated marketing investment.
Molson Coors reaffirmed the following outlook in April:
| 2026 metric | Company guidance |
|---|---|
| Constant-currency net sales | Flat, ±1% |
| Underlying pretax income | Down 15%–18% |
| Underlying EPS | Down 11%–15% |
| Underlying free cash flow | $1.1 billion, ±10% |
| Capital expenditures | $650 million, ±5% |
| Net interest expense | $260 million, ±5% |
| Year-end leverage | Below 2.5x |
Based on 2025 underlying EPS of $5.42, the EPS guidance implies approximately $4.61–$4.82 for 2026.
At TAP’s August 5 close of approximately $41.88, that equates to roughly:
The valuation is inexpensive, but appropriately reflects declining earnings, uncertain category demand and questions about the durability of Molson Coors’ major U.S. brands.
Management guided U.S. financial volumes down 6%–9% in Q2, but said shipments would trail brand volumes. The gap is important.
The shipment decline reflects several factors beyond end demand:
A result within the 6%–9% range would not necessarily be alarming if U.S. brand volumes and retail sales are materially better. Conversely, weak brand volumes combined with weak shipments would suggest that the problem is demand, not timing.
Positive outcome: U.S. brand volumes decline modestly, the shipment result stays within guidance, and management maintains that second-half shipments will outpace consumption.
Negative outcome: Shipments fall more than 9%, availability issues damage summer execution, or management removes the expected second-half shipment recovery.
The U.S. beer market was down approximately 1.6% in Q1, better than management initially expected, but Molson Coors lost roughly 60 basis points of volume share.
The brand-level picture was mixed:
Q2 included major beer-drinking occasions, including the World Cup and America’s 250th anniversary campaign. Molson Coors described its World Cup program as its largest media investment in years.
Investors should look for evidence that this spending produced:
Management previously said share should improve over the balance of the year relative to Q1. That claim will be difficult to maintain if the Q2 exit rate did not improve.
The margin comparison may be the quarter’s biggest source of headline weakness.
Molson Coors incurred approximately $30 million of incremental Midwest Premium cost in Q1. Management said:
Hedges should limit the effect of more recent commodity-price moves, but they do not eliminate the significant year-over-year pressure already embedded in the outlook.
Q1 MG&A fell 9.1% in constant currency. Q2 should move sharply in the opposite direction because of:
Investors should therefore avoid extrapolating Q1’s 16% underlying pretax-income growth.
The key issue is whether the cost spike remains consistent with the full-year guide. If management says commodity inflation or commercial spending has moved materially above plan, the current pretax-income range may become difficult to defend.
Current guidance requires a meaningful improvement after Q2.
The expected bridge includes:
The bar is not necessarily high for absolute growth—the company still guides to a substantial annual earnings decline—but the required sequential improvement matters.
Investors should listen for quantification of:
A reaffirmation without a credible second-half bridge would be less reassuring than the headline suggests.
Molson Coors acquired Atomic Brands, the owner of Monaco Cocktails, for $275 million on April 1.
Management expects Monaco to:
Q2 will be the first full quarter to include Monaco. Investors should focus on organic shipment momentum and distribution gains rather than simply the reported acquisition contribution.
The broader portfolio indicators also matter:
The acquisition helps the growth narrative, but at roughly 1% of sales it cannot compensate for sustained weakness in Coors Light, Miller Lite and the value portfolio.
In Q1, EMEA and APAC reported:
The U.K. was particularly challenging because of soft demand and aggressive competitive pricing affecting Madrí. The region is also dealing with input inflation, geopolitical uncertainty and restructuring actions, including a planned U.K. brewery closure.
There is an additional leadership consideration: EMEA and APAC CEO Philip Whitehead began a medical leave in June, with Simon Kerry appointed interim managing director.
The market will want to see:
Capital returns remain an important part of the TAP thesis.
In Q1, Molson Coors:
The company subsequently issued:
The offerings generated approximately $1.85 billion of net proceeds, primarily to refinance 2026 maturities.
The refinancing removes a near-term maturity issue, although the higher coupons reinforce the importance of achieving the company’s $260 million net-interest forecast. Management still intends to finish 2026 below 2.5x leverage.
Watch for:
A constructive result would include most of the following:
The thesis would weaken if:
TAP enters Q2 with low expectations, a low valuation and a quarter that management has already identified as unusually difficult. That creates potential for a positive reaction even if reported earnings decline sharply.
The most important distinction is between temporary shipment and cost phasing and structural brand weakness. If consumption trends improve, supply issues clear and management confidently reaffirms the second-half recovery, the quarter could mark the low point for the 2026 earnings cycle.
If brand volumes and market share deteriorate alongside the known shipment and cost headwinds, however, the stock’s roughly nine-times earnings valuation may prove to be a value trap rather than an opportunity.
Sources: Molson Coors earnings releases, SEC filings and earnings-call transcripts through August 6, 2026; stock price through the August 5 close.